Abstract
Objective
To identify and quantify potential risk factors for osteoarthritis (OA) following traumatic knee injury.
Design
Systematic review and meta-analyses that estimated the odds of OA for individual risk factors assessed in more than four studies using random-effects models. Remaining risk factors underwent semiquantitative synthesis. The modified GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach for prognostic factors guided the assessment.
Data sources
MEDLINE, EMBASE, CENTRAL, SPORTDiscus, CINAHL searched from inception to 2009–2021.
Eligibility
Randomised controlled trials and cohort studies assessing risk factors for symptomatic or structural OA in persons with a traumatic knee injury, mean injury age ≤30 years and minimum 2-year follow-up.
Results
Across 66 included studies, 81 unique potential risk factors were identified. High risk of bias due to attrition or confounding was present in 64% and 49% of studies, respectively. Ten risk factors for structural OA underwent meta-analysis (sex, rehabilitation for anterior cruciate ligament (ACL) tear, ACL reconstruction (ACLR), ACLR age, ACLR body mass index, ACLR graft source, ACLR graft augmentation, ACLR+cartilage injury, ACLR+partial meniscectomy, ACLR+total medial meniscectomy). Very-low certainty evidence suggests increased odds of structural OA related to ACLR+cartilage injury (OR=2.31; 95% CI 1.35 to 3.94), ACLR+partial meniscectomy (OR=1.87; 1.45 to 2.42) and ACLR+total medial meniscectomy (OR=3.14; 2.20 to 4.48). Semiquantitative syntheses identified moderate-certainty evidence that cruciate ligament, collateral ligament, meniscal, chondral, patellar/tibiofemoral dislocation, fracture and multistructure injuries increase the odds of symptomatic OA.
Conclusion
Moderate-certainty evidence suggests that various single and multistructure knee injuries (beyond ACL tears) increase the odds of symptomatic OA. Risk factor heterogeneity, high risk of bias, and inconsistency in risk factors and OA definition make identifying treatment targets for preventing post-traumatic knee OA challenging.
Keywords: anterior cruciate ligament, meniscus, risk factor, osteoarthritis
What are the findings?
Anterior cruciate ligament (ACL) tears with a medial meniscal injury and/or meniscectomy, and isolated meniscal injuries are associated with an increased risk of structural knee osteoarthritis (OA).
Little is known about the risk factors for symptomatic or structural knee OA after non-ACL tear-related knee injuries, or after an ACL tear beyond meniscal injury or meniscectomy.
It is unclear if there are modifiable risk factors after a traumatic knee injury that can be targeted to prevent symptomatic or structural OA.
How might it impact on clinical practice in the future?
Non-modifiable risk factors: There is moderate-certainty evidence that the odds of symptomatic knee OA increased with various single (cruciate ligament, collateral ligament, meniscus, chondral, fracture or dislocation) and multistructure knee injuries (ACL with meniscal injuries and patellar dislocation with chondral injuries).
Modifiable risk factors: It is challenging to identify ‘treatment targets’ to prevent symptomatic or structural knee OA after a traumatic knee injury due to the heterogeneity in potential risk factors assessed, low-certainty of evidence, and inconsistency in how risk factors and osteoarthritis have been operationalised, measured and analysed.
In the absence of high-certainty evidence for modifiable risk factors for OA after traumatic knee injury, efforts to prevent post-traumatic OA should focus on implementing evidence-based injury prevention programmes and addressing modifiable risk factors for non-traumatic OA (eg, minimise unhealthy adiposity and quadriceps weakness) after a wide range of knee injuries.
Background
Osteoarthritis (OA) is the most common joint condition. It affects more than 300 million people worldwide and is a leading cause of pain, disability and socioeconomic costs.1 2 Post-traumatic OA accounts for at least 12% of OA cases, or 36 million people globally, and commonly involves the knee joint.3
Despite the large burden of OA, there is no cure.4 This leaves prevention as the primary means available to curb the OA epidemic.5 OA prevention can take many forms.6 In the context of post-traumatic knee OA, primary prevention strategies aim to prevent knee joint injuries in susceptible groups; secondary prevention strategies aim to delay or halt the onset of OA after joint injury; while tertiary prevention aims to improve pain and function in those with OA.
Although there is high-level evidence to guide primary7 and tertiary prevention8 of post-traumatic knee OA, considerable gaps remain in our understanding of how to delay or halt the development of OA after a traumatic knee joint injury.9 10 Secondary prevention of post-traumatic knee OA is contingent on knowing who is at risk (target population), identifying modifiable risk factors (treatment targets) and implementing interventions that mitigate these modifiable risk factors (treatments).11 A 2015 systematic review narratively summarised the risk factors for structural tibiofemoral and/or patellofemoral OA after anterior cruciate ligament (ACL) injury.12 It is unknown if these findings extend to other knee injuries, to symptomatic knee OA, or if studies reported since 2015 can address the inconclusive findings.
The primary objective of this research was to identify and quantify the magnitude of potential modifiable and non-modifiable risk factors for symptomatic and structural knee OA following traumatic knee injury. This review is one of seven informing an evidence-based consensus (OPTIKNEE) developing recommendations to guide rehabilitation to prevent post-traumatic knee OA.
Methods
Registration
This review was registered on the Open Science Framework on 7 August 2020 (https://osf.io/bkhr5/).
Framework
The Cochrane Handbook,13 Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines14 and PRISMA-Search extension15 informed the conduct and reporting of this review.
Data sources and search
Relevant studies were identified by searching five databases (Medline-Ovid, EMBASE-Ovid, CENTRAL-Ovid, SPORTDiscus-EBSCOhost, CINAHL-EBSCOhost). Search strategies consisted of medical subject headings and text words related to traumatic knee injury, risk or prognosis, and knee OA with limits for study design and English language. The Medline search strategy was developed in consultation with a health sciences librarian and adapted for other databases. All search strategies are presented in the online supplemental file. Searches were documented and reference lists of identified systematic reviews and included studies hand-searched to identify additional relevant records. Records were transferred to a reference management software (EndNote V.X1).
bjsports-2022-105496supp001.pdf (1.4MB, pdf)
Eligibility
Randomised controlled trials (RCTs) and cohort studies (prospective and retrospective) that assessed a potential risk factor for an outcome of symptomatic or structural knee OA over a minimum 2-year period after a traumatic knee injury in persons with a mean age at injury ≤30 years were included. Traumatic knee injury was defined as an isolated or combined traumatic tibiofemoral or patellafemoral (eg, ligament, meniscal, cartilage, subluxation, dislocation, fracture) injury. Symptomatic OA outcomes could include symptomatic radiographic OA, physician diagnosis, diagnostic code, endorsed evidence-based criteria16–18 or arthroplasty. Structural OA outcomes could include radiographic or MRI-based definitions. A minimum 2-year follow-up period was chosen as radiographic OA can be present 2 years following knee trauma.19 To maximise relevance to current day surgical and rehabilitation procedures, only studies published after 1999 were included. A mean age of injury ≤30 years was chosen to minimise the inclusion of degenerative meniscal lesions.20 Only studies measuring a risk factor(s) prior to an OA outcome, including exposed and unexposed participants, and compared OA prevalence between levels of risk factor exposure were included.11 Studies reporting data from the same cohort were included if they assessed different risk factors or reported estimates at different follow-up periods. We excluded studies that did not report knee trauma, including participants with OA at baseline, or did not operationalise OA unless data that allowed us to apply a definition were provided.
Study selection
After duplicate removal (EndNote V.XI), records were imported into a screening and data extraction platform (Covidence, Veritas Health Innovation). The authors (JML, JBT, LKT, BLvM, MvM, JLW) independently screened titles and corresponding abstracts in duplicate to determine potentially relevant records, followed by full-text review to determine final record selection. Disagreements were resolved through consensus or third author when needed. All decisions and inclusion and exclusion reasons were recorded (Covidence).
Data extraction
The authors (JML, JBT, LKT, ML, MvM, BLvM, MM, JLW) independently performed data extraction, in duplicate using a structured data extraction form (Covidence). Data extraction was guided by prognostic factor review recommendations21 and included study information (first author, publication date, title, location, design, aim, population, recruitment methods, inclusion and exclusion criteria, primary exposure and outcome variables, statistical tests, funding sources, conflicts of interest); participant characteristics (sample description, primary injury, time from injury to baseline, sex, age at injury, body mass index (BMI) at injury); treatment approach; follow-up duration (start and end date); risk factor(s) assessed and comparison condition; study attrition by exposure status; OA definition (method, definition, joints assessed); and results including number of total, exposed, unexposed participants, OA prevalence, unadjusted and/or adjusted estimate of OA odds or risk for each risk factor (OR, risk ratio (RR), HR with 95% CIs). When studies reported univariable and multivariable estimates, only multivariable estimates were extracted.
Risk of bias
The authors (JML, JBT, LKT, ML, BLvM, MvM, JLW) independently assessed risk of bias across included studies in duplicate using the Quality in Prognosis Studies (QUIPS) tool.22 Disagreements were resolved through consensus or third author when needed. The potential for selection, attrition and measurement bias for both risk factors and OA outcome, and bias due to confounding and statistical analysis were categorised as low, moderate or high based on signalling questions.21 22 Signalling question criteria (online supplemental file) were agreed on ‘a priori’ and operationalised based on expert knowledge, comparable reviews23 24 and domain-specific guidance (eg, missing data).21 22 25
Data synthesis
Data synthesis involved four steps. First, unique potential risk factors were identified and categorised by demographics, injury or treatment type. Second, matrices of potential risk factors for symptomatic and structural OA stratified by injury type and follow-up length were created. Third, univariate OR (95% CI) of OA for potential risk factors assessed in studies that only reported a p value when raw data was available were calculated. If necessary, accepted definitions of structural OA were applied to data where authors had not operationalised OA, but raw data were available (ie, KL Grade ≥2,26 Ahlback ≥1,27 Fairbanks ≥2,28 IKDC≥Grade B29 and patellofemoral joint osteophyte grade ≥1).26 Lastly, quantitative (meta-analysis) or semiquantitative synthesis was conducted, and certainty of evidence ratings assigned. Meta-analyses were performed for individual potential risk factors where there are more than four studies with OR (95% CI) of symptomatic or structural knee OA. Semiquantitative analyses were performed for potential risk factors with insufficient data for meta-analysis.30 Certainty ratings were generated by one author (JML), checked for accuracy by the lead author (JLW) and discrepancies resolved by consensus.
Quantitative synthesis
Statistical analyses were performed in R V.4.1.0 (R Core Team, Austria) using the ‘meta’ and ‘tidyverse’ packages. The pooled relative odds of OA for a given risk factor was estimated using a logarithmic transformed inverse variance-weighted (restricted maximum likelihood) random effects models with results back transformed and presented as ORs (95% CI). If possible, analyses were stratified by overall knee joint and joint compartment (total joint, tibiofemoral, medial tibiofemoral, lateral tibiofemoral, patellofemoral) OA; injury type (isolated ACL tear, ACL tear with concomitant injury, non-ACL-related injury); and follow-up time. Random effects models were chosen given the large expected heterogeneity in the methods used to assess and compare individual risk factors; length of time between injury and OA; and OA definition. Heterogeneity was assessed as the between-study variance (Tau2) and proportion of variance attributable to between-study inconsistency (I2). 31 32 When a risk factor was presented as both continuous and dichotomous variables across studies, the dichotomous scale was transformed to a continuous variable following Cochrane Handbook13 guidance if possible. In cases where a risk factor was assessed at various timepoints in the same cohort, only estimates from the furthest timepoint were included. ORs were chosen as the effect estimate as most studies in this field use logistic regression and do not present data required to recalculate risk or HR (95% CI).
After meta-analyses, the overall certainty of evidence for estimates of individual risk factors was rated as ‘high,’ or downgraded to ‘moderate’, ‘low’ or ‘very low’ using the modified GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach for prognostic factor reviews.30 Briefly, the certainty of evidence was assessed across six domains including phase of investigation (strength of prognostic factor study design on a continuum from identifying, to confirming or understanding a prognostic pathway)33; methodological weaknesses (risk of bias based on QUIPs); heterogeneity of results (inconsistency in sample and methods); generalisability of findings to the target population (indirectness); estimate precision (95% CI width); and risk of publication bias.30
Semiquantitative synthesis
Semiquantitative synthesis30 involved rating the certainty of evidence for potential risk factors using the same modified GRADE approach30 adapted for non-pooled data (see online supplemental file).33 34 All domain ratings were considered when assigning an overall rating30 and a corresponding statement of certainty in the direction (considering consistency across studies), and magnitude of the risk factor and OA relationship was generated.
Patient and public involvement
Two individuals with lived experience of ACL tear (and ACLR) and four clinicians (physiotherapists, orthopaedic surgeons) contributed to the priority theme setting of this review through the OPTIKNEE consensus. A patient partner (MM) was involved in the design, execution and dissemination of this study (see the Contributions section).
Results
Sixty-six studies were included in the review (figure 1). These studies were published between 2000 and 2021, and included at total of 873 785 participants (73 852 with ACL-related injuries, 11 982 with non-ACL-related injuries and 787 951 uninjured) from 48 unique cohorts.
Figure 1.
PRISMA flowchart. OA, osteoarthritis; PRISMA, Preferred Reporting Items for Systematic reviews and Meta-Analyses; RCT, randomised controlled trial.
Study characteristics
Included studies are summarised in the online supplemental file. Twenty-four were RCTs,35–58 17 were prospective cohort studies29 59–74 and 25 were retrospective cohort studies.28 75–98 Fifty-eight (89%) of the studies assessed participants with an ACL tear (with and without concomitant injuries),29 35–44 46–71 73–89 91 92 94 98 three (5%) considered multiple knee injuries,72 93 97 two (4%) meniscal injuries only,28 90 one (2%) cartilage injuries only45 and one (2%) patellar dislocations only.96 Only eight (12%) of the studies assessed risk factors for symptomatic OA (four ICD-9 or 10 diagnostic codes for OA, two physician chart, one symptomatic radiographic, one KOOS (Knee Injury and Osteoarthritis Outcome Score)).37 80 88 90 93 95–97 In contrast, 50 (76%) assessed risk factors for structural OA alone (49 radiographs, 1 MRI),28 29 35 36 38–60 62–64 68–73 75 76 78 79 81–84 86 87 91 92 94 98 and 8 (12%) assessed risk factors for both (eight symptomatic radiographic).61 65–67 74 77 85 89 Radiographic definitions of OA were based on a variety of grading systems including the KL (n=29),35 38 39 45–49 54 56 57 59 61 65–67 70 71 74 77 79 80 83–87 89 98 IKDC (n=15),29 51–53 58 60 62 68 69 75 76 78 91 92 94 Ahlback (n=10),28 36 39–43 49 55 59 OARSI Atlas (n=5),37 44 63 64 73 81 Fairbank (n=4),28 36 39 82 Iwano (n=2)40 96 and modified Ahlback and Fairbank (n=1)50 approaches, while the MRI definition was based on MOAKS (n=1)72 grading. Follow-up times ranged from 2 to 37 years, with 40 (61%) having a 6–15 year follow-up (figures 2 and 3).
Figure 2.
Overview of potential risk factors for symptomatic knee OA by follow-up time and knee injury type. To provide an overview of what potential risk factors have been assessed at what timepoints, cohort studies that assessed a risk factor at multiple follow-up points are represented more than once. Apparent redundancies in risk factors are based on differences in definitions use across included studies (eg, terminology used to describe injuries that involved more than one structure). ACL, anterior cruciate ligament; ACLRc, ACL tear reconstruction; ACLRp, ACL tear repair; Ant, anterior; BMI, body mass index; Ext, extension; Flex, flexion; fu, follow-up; Knee injury, inclusive of several injury types; OAT, osteochondral autograft transfer; PF, patellofemoral; ROM, range of motion; RTS, return to sport; TF, tibiofemoral joint; yrs, years. 1Rehabilitation information provided. 2Intervention no reported. 3Past, present or future. 4Present or future. 5Serum.
Figure 3.
Overview of potential risk factors for structural knee OA by follow-up time and knee injury type. To provide an overview of what potential risk factors have been assessed at what timepoints, cohort studies that assessed a risk factor at multiple follow-up points are represented more than once. ACL, anterior cruciate ligament; ACLRc, ACL tear reconstruction; ACLRp, ACL tear repair; Ant, anterior; BMI, body mass index; Ext, extension; Flex, flexion; Knee injury, inclusive of several injury types; OAT, osteochondral autograft transfer; ROM, range of motion; RTS, return to sport; TF, tibiofemoral joint; yrs (years). 1Rehabilitation information provided. 2Intervention no reported. 3Past, present or future. 4Present or future. 5Serum.
Risk factors
Across included studies, 81 unique potential risk factors were identified including 46 for symptomatic OA and 62 for structural OA, spanning 10 broad categories (figures 2 and 3). Categories included demographics (n=19)38 54 59 60 66 67 69 74–76 78 80 81 83 84 89 94–96; follow-up time (n=5)38 54 75 84 89; injury type (n=22)29 41 51 59 64–68 70–72 76 81 84 88 89 93 95–98; treatment approach (n=14)44 50 61 64 71 72 74 80 83 85 87 88 95 98; surgery type (n=30)28 29 38 40 44 45 50 51 53 59 61 64 69 71 72 74–76 78 80 81 83–85 87 88 90 95 96 98; ACL reconstruction (ACLR) surgical technique (n=9)37 40–43 47 48 50 55; ACLR graft choice (n=20)35 36 38 39 46 49 51–53 56–58 62 66 81 86 91 92 94 95; post-ACL injury or ACLR status (n=17)29 38 59 62 66 69 71 73 74 76–82 89 91 94; joint morphology (n=2)75 96; and biomarkers (n=1).63 Twenty-seven (59%) of the 46 potential risk factors for symptomatic OA and 39 (63%) of the 62 potential risk factors for structural OA were assessed in only one study. Further, 13 (81%) and 34 (57%) of the studies assessing symptomatic and structural knee OA considered multiple potential risk factors, respectively.
Odds and risk of osteoarthritis
With respect to potential risk factors for symptomatic OA, nine (14%) studies estimated or provided data to calculate OR (95% CI), one (1.5%) reported RR (95% CI), and eight (12.5%) reported HR (95% CI; see online supplemental file). In contrast, for potential risk factors for structural OA, 55 (92%) studies estimated or provided data to calculate OR (95% CI), while two reported RR (95% CI; see online supplemental file).
Risk of bias
The results of the risk of bias assessment are summarised in table 1. Only four studies (6%)44 88 90 97 were judged to be at low risk of bias across all domains. Most studies were judged to be at high risk of bias due to participant attrition (n=42, 64%) and inadequate control of confounding (n=32, 49%). Thirty-eight (58%) studies were judged to have low risk of bias in risk factor measurement.
Table 1.
Chronological summary of risk of bias assessment (QUIPS)
| Study | Selection bias | Attrition bias | Measurement bias (exposure) |
Measurement bias (outcome) |
Bias due to confounding | Bias in statistical analysis |
| Rockborn and Gillquist28 | Moderate | High | Low | Moderate | High | High |
| Drogset and Grøntvedt41 | Low | High | Low | Low | High | Moderate |
| Pinczewski et al 92 | Moderate | High | Low | High | High | High |
| Jonsson et al 82 | High | Moderate | Moderate | High | High | High |
| Lohmander et a 85 | Low | High | Low | Low | Moderate | Low |
| von Porat et al 98 | Low | High | Low | Low | High | Moderate |
| Roe et al 94 | Low | High | Low | Moderate | High | High |
| Drogest et al 42 | Low | High | Low | Low | High | Moderate |
| Sajovic et al 52 | Moderate | High | Low | High | Moderate | Moderate |
| Meunier et al 50 | Moderate | High | Moderate | Moderate | High | High |
| Pinczewski et al 91 | Moderate | High | Moderate | High | High | High |
| Kessler et al 83 | Moderate | High | Low | Moderate | Moderate | High |
| Meuffels et al 87 | High | High | Low | Low | Moderate | High |
| Neumann et al 64 | Low | Moderate | Moderate | Low | High | Moderate |
| Ahldén et al 36 | Moderate | High | Low | Moderate | High | High |
| Holm et al 47 | Low | Moderate | Low | Low | Moderate | Low |
| Mascarenhas et al 86 | High | High | Moderate | High | High | High |
| Li et al 84 | Moderate | Moderate | Moderate | Moderate | High | Moderate |
| Sajovic et al 53 | Moderate | High | Low | High | Moderate | Moderate |
| Ahn et al 75 | Low | Moderate | Moderate | Low | Moderate | Low |
| Gudas et al 45 | Low | Moderate | Low | Moderate | Moderate | Moderate |
| Holm et al 46 | Moderate | Moderate | Low | Low | Moderate | Low |
| Øiestad et al 65 | Low | High | High | Low | High | Moderate |
| Øiestad et al 66 | Low | Moderate | Low | Low | High | Moderate |
| Leys et al 62 | Moderate | High | Low | Moderate | High | High |
| Shelbourne et al 29 | Moderate | High | Moderate | Moderate | High | Moderate |
| Frobell et al 44 | Low | Low | Low | Low | Low | Low |
| Gifstad et al 79 | High | High | Low | Low | High | High |
| Janssen et al 59 | Moderate | High | Moderate | Low | High | Low |
| Barenius et al 38 | Moderate | Moderate | Low | Moderate | Moderate | Low |
| Nordenvall et al 88 | Low | Low | Low | Low | Low | Low |
| Shelbourne et al 68 | Moderate | High | High | Moderate | High | Moderate |
| Sun et al 58 | High | Migh | Moderate | Moderate | High | Moderate |
| Björnsson et al 39 | Moderate | High | Moderate | Moderate | High | Moderate |
| Cantin et al 76 | Moderate | High | High | Moderate | High | High |
| Johnson et al 60 | Moderate | High | Low | Moderate | High | Moderate |
| Karikis et al 49 | Moderate | Moderate | Low | Moderate | Low | Low |
| Risberg et al 67 | Moderate | Low | Low | Low | High | Moderate |
| Sanders et al 95 | Moderate | Moderate | Moderate | High | High | Low |
| Webster et al 56 | Moderate | High | Low | Moderate | High | Moderate |
| Akelman et al 37 | Low | High | Moderate | Low | High | Moderate |
| Culvenor et al 77 | Low | Moderate | Moderate | Moderate | Low | Low |
| Neumann et al 63 | Moderate | High | Moderate | Low | Moderate | Low |
| Sanders et al 96 | Low | High | Low | Low | Low | Low |
| Shelbourne et al 69 | Moderate | Moderate | Moderate | Moderate | Moderate | Low |
| Ulstein et al 70 | Low | High | Moderate | Moderate | Moderate | Moderate |
| Yoo et al 57 | Low | High | Moderate | Moderate | High | Moderate |
| Aga et al 35 | Low | Moderate | Low | Moderate | Low | Moderate |
| Elveos et al 43 | High | High | Low | Low | High | Moderate |
| Øiestad et al 89 | Moderate | High | Low | Low | Low | Low |
| Persson et al 90 | Low | Low | Low | Low | Low | Low |
| Rhon et al 93 | Low | High | Moderate | Moderate | Moderate | Low |
| Sajovic et al 51 | High | High | Low | High | Moderate | Moderate |
| Wellsandt et al 71 | Low | High | Moderate | Low | Moderate | Low |
| Whittaker et al 72 | Low | Moderate | Low | Low | Low | Low |
| Curado et al 78 | High | High | Moderate | Moderate | High | Moderate |
| Hagmeijer et al 80 | Moderate | Low | Moderate | Moderate | Moderate | Moderate |
| Hoogeslag et al 48 | Moderate | High | Low | Moderate | Low | Moderate |
| Hamrin Senorski et al 54 | Low | High | Moderate | Moderate | Low | Low |
| Jones et al 81 | Low | Moderate | Moderate | Moderate | Moderate | Low |
| Sporsheim et al 55 | Low | Moderate | Moderate | Low | High | Moderate |
| Castoldi et al 40 | Moderate | Moderate | Low | Low | Moderate | Low |
| Kvist et al 61 | Moderate | High | Low | Low | Moderate | High |
| Snoeker et al 97 | Low | Low | Low | Low | Low | Low |
| Filbay et al 74 | Moderate | High | Low | Low | Moderate | Low |
| Haberfield et al 73 | Moderate | High | Low | Low | Low | Moderate |
| Summary | ||||||
| % high ROB | 12.1 | 63.6 | 4.5 | 12.1 | 48.5 | 21.2 |
| % moderate ROB | 47.0 | 27.3 | 37.9 | 42.4 | 31.8 | 42.4 |
| % low ROB | 40.9 | 9.1 | 57.6 | 45.5 | 19.7 | 36.4 |
Studies are in chronological order from earliest to most recent to show possible temporal trends.
QUIPS, Quality in Prognosis Studies; ROB, risk of bias.
Meta-analyses
Across all potential risk factors, 6 (15%) for symptomatic OA and 16 (26%) for structural OA were assessed in more than four studies. Of these, none of the risk factors for symptomatic OA, and only 10 for structural OA (ie, sex, rehabilitation for ACL tear, ACLR for ACL tear, ACLR age, ACLR BMI, ACLR graft source, ACLR graft augmentation, ACLR with cartilage injury, ACLR plus partial meniscectomy and ACLR plus total medial meniscectomy) were eligible for meta-analysis. Ineligibility was due to insufficient data, or heterogeneity in the reported statistic (ie, OR, RR, HR), comparison condition or joint compartment assessed.
GRADE ratings suggested very-low certainty evidence that the odds of structural knee OA were increased after ACLR with concomitant cartilage injury (OR 2.31, 95% CI 1.35 to 3.94, I2=58%), ACLR with partial meniscectomy (OR 1.87, 95% CI 1.45 to 2.42, I2=44%) and ACLR with total medial meniscectomy (OR 3.14, 95% CI 2.20 to 4.48, I2=0%). No other statistically significant associations were found. Figure 4 summarises the pooled estimated OR (95% CI) and heterogeneity of meta-analyses (individual analyses in the online supplemental file), while table 2 summarises the GRADE rating, overall confidence and direction and magnitude for each risk factor. Potentially important heterogeneity was present for five of ten potential risk factors. Overall, the evidence for all meta-analyses was judged as ‘very-low certainty’ due to lower strength of study design (phase I and phase II studies), very serious risk of bias (8/10), inconsistency (5/10), indirectness (5/10), imprecision (4/10), publication bias (5/10) or no upgrading factors (5/10 studies).
Figure 4.
Forest plots for risk factor meta-analyses for structural knee OA (stratified by joint compartment). Odds (OR, 95% CI) of structural knee OA by risk factor both stratified by joint compartment (ie, unspecified knee joint compartment, total tibiofemoral joint compartment, medial tibiofemoral joint compartment) and combined across joint compartments. ‘Unspecified joint compartment’ was used when it was not clear which knee joint compartment(s) were assessed. Follow-up is presented in year range. ACLR, anterior cruciate ligament reconstruction; ACL, anterior cruciate ligament; BMI, body mass index; NA, I2 could not be calculated based on one study; yrs, years. 1Reference group is female sex. 2Samples include ACL injured persons only. 3Rehabilitation for ACL tear is stratified by comparison condition (ie, rehabilitation or delayed ACLR) not joint compartment thus estimates represent OA in any knee compartment. Frobell et al,44 Kvist et al 61 and Neuman et al 64 assessed tibiofemoral and patellofemoral OA with the tibiofemoral estimates included in meta-analyses, Meuffels et al 87 assessed tibiofemoral OA (based on radiographic views reported), Wellsandt et al 71 assessed tibiofemoral OA but only report medial tibiofemoral compartment estimates, while Kessler et al 83 did not specify joint compartment. 4Reference is no ACLR. 5Odds for every 1 year increase in age. 6Odds for everyone one kg/m2 increase in BMI. 7Reference is semitendinosus tendon autograft. 8Reference is ACLR or ACL repair with no graft augmentation. 9Reference is no cartilage injury or less severe cartilage injury at ACLR.10Reference is ACLR with no meniscectomy.11Reference is ACLR with no total medial meniscectomy.
Table 2.
Summary of evidence of risk factors for structural knee OA (meta-analysis)
| Risk factor | Follow-up (years) and participants (n) |
Phase of investigation (number of studies) | ROB* | Inconsistency | Indirectness | Imprecision | Publication bias | Upgrading factors | Modified GRADE | Certainty, direction and magnitude with structural OA |
| Sex38 74 81 89 112 | 2–37 (892) | Phase I (1) Phase II (3) |
X | ✓ | X | ✓ | ✓ | X | + | Very low certainty that male sex may† ↑ OA odds up to 1.25 times (95% CI 0.92 to 1.70) |
| Rehabilitation44 61 64 71 83 87 | 5–37 (588) | Phase I (4) Phase II (2) |
XX | X | ✓ | X | ✓ | X | + | Very low certainty of no difference in the OA odds between ACL tear management with rehabilitation vs ACLRc or delayed ACLRc |
| ACLRc44 61 71 83 85 87 | 5–37 (612) | Phase I (3) Phase II (3) |
X | X | ✓ | X | ✓ | X | + | Very low certainty of no difference in OA odds between ACL tear management with an ACLRc or not |
| Age at ACLRc59 69 75 76 81 89 | 2–23 (1846) | Phase I (4) Phase II (2) |
XX | X | X | ✓ | X | X | + | Very low certainty that each 1 year ↑ in age at ACLR may† ↑ OA odds up to 1.36 times (95% CI 0.95 to 1.96) |
| BMI at ACLRc75 81 83 84 | 2–11 (896) | Phase I (2) Phase II (2) |
XX | X | X | X | X | X | + | Very low certainty of no difference in OA odds based on BMI at ACLR |
| ACLRc graft source36 38 39 46 53 56 62 66 81 | 2–17 (1166) | Phase I (2) Phase II (7) |
XX | ✓ | ✓ | X | ✓ | X | + | Very low certainty of no difference in OA odds between a patellar tendon (autograft) and a semitendinosus tendon (autograft) |
| ACLRc graft augmentation40 42 43 50 | 15–25 (297) | Phase I (1) Phase II (3) |
XX | ✓ | X | ✓ | X | ✓ | + | Very low certainty that ACL surgery‡ with graft augmentation may† ↓ OA odds 0.51 (0.24 to 1.05) times vs ACL surgery with no augmentation |
| Cartilage injury at ACLRc29 41 51 70 81 84 | 2–17 (1693) | Phase I (3) Phase II (4) |
XX | X | ✓ | ✓ | ✓ | ✓ | + | Very low certainty that cartilage injury at ACLRc ↑ OA odds 2.31 times (1.35 to 3.94) compared with either no or less severe injury at ACLRc |
| ACLRc+partial meniscectomy29 51 75 81 | 2–17 (2007) | Phase I (1) Phase II (3) |
XX | ✓ | X | ✓ | X | X | + | Very low certainty that ACLRc+partial meniscectomy ↑ OA odds 1.87 times (1.45 to 2.42) compared with ACLRc alone |
| ACLRc+medial meniscectomy38 59 69 84 | 8–23 (892) | Phase I (3) Phase II (1) |
XX | ✓ | ✓ | ✓ | X | ✓ | + | Very low certainty that ACLRc+medial meniscectomy ↑ OA odds 3.14 times (2.20 to 4.48) compared with ACLRc alone |
*Assessed with QUIPS.
†95% CI include the null value and lower CI limit was ≥0.90 or upper CI limit was ≤1.1.
‡ACL surgery refers to ACL reconstruction or ACL repair.
+++, moderate-certainty evidence; +, very low-certainty evidence; ✓, no limitations; ++, low-certainty evidence; ++++, high-certainty evidence; ACL, ACL tear; ACLnoSx, ACL tear with no sx; ACLRc, ACL reconstruction; GRADE, Grading of Recommendations Assessment, Development and Evaluation; n, number; OA, osteoarthritis; PFJ, patellofemoral joint; ROB, risk of bias; SR, self-reported; Sx, surgery; TF, tibiofemoral; X, serious limitations; x, times; XX, very serious limitations.
Semiquantitative analyses
The results of the semiquantitative analyses for symptomatic and structural OA are summarised in tables 3 and 4, respectively. Potential risk factors for symptomatic OA were mostly assessed in phase II (confirmatory) and phase III (explanatory) studies with large sample sizes, and low-to-moderate risk of bias resulting in certainty of evidence ratings spanning high (27%), moderate (7%) low (22%) and very low (44%). In contrast, risk factors for structural OA were mostly assessed in phase I (exploratory) and phase II (confirmatory) studies with relatively smaller samples, higher risk of bias and conflicting results leading to certainty of evidence ratings of moderate (8%), low (16%) and very low (76%).
Table 3.
Summary of evidence of risk factors for symptomatic knee OA (semiquantitative synthesis)
| Risk factor | Follow-up (years) and participants (n) |
Phase of investigation (number of studies) |
ROB | Inconsistency | Indirectness | Imprecision | Publication bias | Upgrading factors | Modified GRADE | Direction and magnitude* of relationship with symptomatic OA |
| Sex66 74 89 95 96 | 12–37 (3400) | Phase I (3) Phase II (2) |
X | X | ✓ | X | ✓ | X | + | Sex may not change OA odds |
| Age at injury80 95 96 | 12–18 (3095) | Phase I (2) Phase II (1) |
X | ✓ | ✓ | ✓ | ✓ | X | ++ | Older injury age may ↑ OA risk up to 1.1 times/year |
| Age at surgery89 | 15 (210) | Phase II (1) | X | Unclear | X | ✓ | ✓ | X | + | Association of surgery age and OA odds is unclear |
| Injury to surgery89 | 15 (210) | Phase II (1) | X | Unclear | X | ✓ | ✓ | X | + | Association of time from injury to surgery and OA odds is unclear |
| Multistructure injury 97 | 19 (148 072) | Phase II (1) | ✓ | Unclear | ✓ | ✓ | ✓ | ✓ | +++ | Multistructure injuries (vs isolated) may ↑ OA risk 3.2 times by 19 years |
| Cruciate ligament tear 97 | 19 (148 072) | Phase III (1) | ✓ | Unclear | ✓ | ✓ | ✓ | ✓ | +++ | Cruciate ligament tears may ↑ OA risk 6.8 times by 19 years |
| ACL+concomitant injury 74 89 113 | 15–37 (68 974) |
Phase I (2) Phase II (2) Phase III (1) |
X | ✓ | ✓ | ✓ | ✓ | ✓ | +++ | ACL+concomitant injury may ↑ OA odds up to 5.9 times |
| ACL+chondral injury95 | 14 (1928) | Phase I (1) | XX | Unclear | ✓ | X | ✓ | X | + | Association of ACL+chondral injury and OA odds is unclear |
| ACL+meniscal injury88 95 | 9–14 (66 542) | Phase I (1) Phase III (1) |
X | Unclear | X | Unclear | ✓ | X | + | Association of ACL+meniscal injury and OA odds is unclear |
| Collateral ligament injury 93 97 | 9–19 (151 677) |
Phase II (1) Phase III (1) |
✓ | Unclear | X | ✓ | ✓ | ✓ | +++ | Collateral ligament injuries may ↑ OA risk up to 2.1 times by 19 years |
| Meniscal injury 93 97 | 9–19 (151,677) |
Phase II (1) Phase III (1) |
✓ | Unclear | X | ✓ | ✓ | ✓ | +++ | Meniscal injuries may ↑ OA risk up to 4.0 times at 19 years |
| Chondral injury 97 | 19 (148,072) | Phase III (1) | ✓ | Unclear | ✓ | ✓ | ✓ | ✓ | +++ | Chondral injuries may ↑ OA risk up to 2.4 times at 19 years |
| Fracture 93 97 | 9–19 (151,677) |
Phase II (1) Phase III (1) |
✓ | Unclear | X | ✓ | ✓ | ✓ | +++ | Fracture may ↑ OA risk up to 7.0 times by 11 years |
| TF dislocation 93 97 | 9–19 (151,677) |
Phase II (1) Phase III (1) |
✓ | Unclear | X | ✓ | ✓ | ✓ | +++ | TF dislocation may ↑ OA risk up to 3.0 times by 19 years |
| PFJ dislocation 96 | 12 (971) | Phase II (1) | X | Unclear | ✓ | ✓ | ✓ | ✓ | +++ | PFJ dislocation may ↑ OA risk up to 7.8 times |
| PFJ dislocation+chondral defect 96 | 12 (971) | Phase II (1) | X | Unclear | ✓ | ✓ | ✓ | ✓ | +++ | PFJ dislocation+chondral defect may ↑ OA risk up to 11.3 times |
| Recurrent PFJ dislocation 96 | 12 (971) | Phase II (1) | X | Unclear | ✓ | ✓ | ✓ | ✓ | +++ | Recurrent PFJ dislocation may ↑ OA risk up to 4.5 vs one dislocation |
| Soft tissue injury93 | 9 (3605) | Phase II (1) | X | Unclear | X | ✓ | ✓ | ✓ | +++ | Association of soft tissue injury† (vs mild‡ injury) and OA odds is unclear |
| ACLnoSx80 85 88 95 | 9–18 (66 841) | Phase I (2) Phase II (1) Phase III (1) |
X | X | ✓ | ✓ | ✓ | X | ++ | Association of ACLnoSx (vs ACLSx) with OA odds is unclear |
| ACLnoSx+exercise therapy61 | 32–37 (153) | Phase I (1) | X | Unclear | ✓ | X | X | X | + | Association of ACLnoSx+exercise (vs ACLSx) with OA odds is unclear |
| ACLRc85 88 95 | 9–14 (66 645) | Phase I (1) Phase II (1) Phase III (1) |
X | ✓ | ✓ | ✓ | ✓ | X | ++ | ACLRc (vs ACLnoSx) may ↑ OA risk up to 6.0 times |
| Early ACLRc61 80 88 95 | 9–37 (66 891) | Phase I (2) Phase III (1) |
XX | ✓ | ✓ | ✓ | ✓ | X | + | Early ACLRc (vs ACLnoSx) may ↑ OA risk up to 1.2 times Association between early vs delayed ACLRC and OA odds is unclear |
| Delayed ACLRc61 80 88 95 | 9–37 (66 891) | Phase I (3) Phase III (1) |
XX | ✓ | ✓ | ✓ | ✓ | X | + | Association of delayed ACLRc and OA risk is unclear |
| ACL or ACLRc+meniscal sx (anytime)74 85 88 | 2–37 (64 717) | Phase I (1) Phase II (1) Phase III (1) |
X | ✓ | X | ✓ | ✓ | X | + | ACLRc+meniscal sx may ↑ OA risk up to 4.8 times |
| ACLRc graft tension37 | 17 (72) | Phase II (1) | X | Unclear | ✓ | X | ✓ | X | + | Association between graft tension and OA odds is unclear |
| ACLRc graft type95 | 14 (1928) | Phase I (1) | XX | Unclear | ✓ | X | ✓ | ✓ | + | Association of ACLRc allograft (vs autograft) and OA odds is unclear |
| ACLRc graft donor site66 | 12 (164) | Phase I (1) | X | Unclear | ✓ | X | ✓ | X | + | Association of patellar (vs semitendinosus) graft and OA odds is unclear |
| Meniscus repair90 | 10 (628 841) | Phase III (1) | ✓ | Unclear | ✓ | ✓ | ✓ | X | ++ | Association of meniscal repair and OA risk is unclear |
| Patellar stabilisation sx96 | 12 (971) | Phase II (1) | X | Unclear | ✓ | Unclear | X | X | + | Association of patella stabilisation sx and OA odds is unclear |
| Anterior tibial motion post ACL or ACLRc74 | 32–37 (127) | Phase I (1) | X | Unclear | ✓ | X | ✓ | X | + | Association of anterior tibial motion and OA odds is unclear |
| AKP post-ACLRc77 | 20 (142) | Phase II (1) | ✓ | Unclear | X | X | ✓ | X | + | Association of AKP post-ACLRc and OA risk is unclear |
| Return to pivoting sport89 | 15 (210) | Phase II (1) | X | Unclear | X | ✓ | ✓ | ✓ | ++ | Association of return to pivot sport and OA odds is unclear |
| TF ROM post-ACL or ACLRc74 | 32–37 (127) | Phase I (1) | X | Unclear | X | X | ✓ | X | + | Association of knee ROM deficits at 4 years and OA odds is unclear |
| Hop post-ACL or ACLRc74 | 32–37 (127) | Phase I (1) | X | Unclear | X | Unclear | ✓ | ✓ | + | Association of hop LSI post ACL or ACLRc and OA odds is unclear |
| Strength post ACL or ACLRc66 74 | 12–37 (291) | Phase I (2) | X | ✓ | X | X | ✓ | X | + | Association of extension strength and OA odds is unclear |
| SR function post-ACL or ACLRc66 74 89 | 12–37 (501) | Phase I (2) Phase II (1) |
X | X | X | Unclear | ✓ | X | + | SR function§ may not change OA odds |
| SR physical activity 4 years post-ACL74 | 32–37 (127) | Phase I (1) | X | Unclear | X | X | ✓ | X | + | Association of Tegner Activity Scale score and OA odds is unclear |
| Patella alta96 | 12 (971) | PhaseII (1) | X | Unclear | X | ✓ | X | X | ++ | Association of patella alta and OA odds is unclear |
| Trochlear dysplasia96 | 12 (971) | Phase II (1) | X | Unclear | X | ✓ | ✓ | ✓ | ++ | Trochlear dysplasia may ↑ OA odds up to 3.6 times |
Bold: Factor(s) with moderate to high quality evidence and OR or RR consistently (more than one analysis) positive, with the largest estimate ≥2.0.
Apparent redundancies in risk factors are based on differences in definitions use across included studies (eg, terminology used to describe injuries that involved more than one structure).
*Unclear (estimates significant in inconsistent directions), may (estimates mostly significant in the same direction or mostly not significant), increase or decrease (estimates consistently significant in the same direction).
†Soft tissue injury (diagnostic code).93
‡Mild knee injury (United States Military Injury Severity score of 0–3).93
§Cincinnati Knee Score ACL and Lysholm Knee Scoring Systems.
+++, moderate-certainty evidence; +, very low-certainty evidence; ++++, high-certainty evidence; ✓, no limitations; ++, low-certainty evidence; ACL, anterior cruciate ligament tear; ACLnoSx, ACL tear with no surgery; ACLRc, ACL reconstruction; AKP, anterior knee pain; GRADE, Grading of Recommendations Assessment, Development and Evaluation; LSI, limb symmetry index; n, number; OA, osteoarthritis; PFJ, patellofemoral joint; ROB, risk of bias; SR, self-reported; Sx, surgery; TF, tibiofemoral; X, serious limitations; XX, very serious limitations.
Table 4.
Summary of evidence of risk factors for structural knee OA (semiquantitative synthesis)
| Risk factor | Follow-up (years) and participants (n) |
Phase of investigation (number of studies) |
ROB | Inconsistency | Indirectness | Imprecision | Publication bias | Upgrading factors | Modified GRADE | Direction and magnitude* with structural OA |
| Age at injury38 | 14 (134) | Phase II (1) | X | Unclear | X | ✓ | ✓ | X | ++ | Association of injury age and OA odds is unclear |
| BMI 2 years post-ACL sx38 | 14 (134) | Phase II (1) | X | Unclear | X | ✓ | ✓ | ✓ | +++ | ↑ BMI 2 years post ACLRc may ↑ MTF and PFJ OA odds up to 3.5 times |
| Pre-injury activity level81 | 2 (421) | Phase II (1) | X | Unclear | X | ✓ | ✓ | X | ++ | Association of pre-injury activity level and OA odds is unclear |
| Manual occupation38 | 14 (134) | Phase II (1) | X | Unclear | X | X | ✓ | X | + | Association of pre-injury occupation and OA odds is unclear |
| Follow-up length84 | 8 (249) | Phase I (1) | XX | Unclear | X | ✓ | ✓ | X | + | Association of longer time since injury and OA odds is unclear |
| Injury to sx38 54 75 89 | 10–16 (585) | Phase I (2) Phase II (2) |
X | ✓ | X | ✓ | ✓ | X | + | Length of time from injury to knee sx may not change OA odds |
| Bilateral knee injury72 | 7 (146) | Phase II (1) | ✓ | Unclear | ✓ | Unclear | Unclear | X | + | Association of bilateral knee injury and OA odds is unclear |
| ACL+concomitant injury 74 89 113 | 15–37 (504) |
Phase I (2) Phase II (1) |
X | ✓ | ✓ | ✓ | ✓ | ✓ | +++ | ACL+concomitant injury (vs ACL only) ↑ OA odds up to 7.5 times |
| Second ACL71 | 5 (84) | Phase I (1) | X | Unclear | ✓ | Unclear | ✓ | X | + | Association of second ACL tear and OA odds is unclear |
| Meniscal injury72 | 7 (146) | Phase II (1) | ✓ | Unclear | ✓ | Unclear | Unclear | X | + | Association of meniscal injury and OA odds is unclear |
| Bilateral knee sx72 | 7 (146) | Phase II (1) | ✓ | Unclear | ✓ | Unclear | Unclear | X | + | Association of bilateral knee sx and OA odds is unclear |
| Index knee sx72 | 7 (146) | Phase II (1) | ✓ | Unclear | ✓ | X | X | ✓ | ++ | Association between index knee sx (vs no injury) and OA odds is unclear |
| ACLnoSx50 85 98 | 12–15 (318) | Phase I (2) Phase II (1) |
XX | ✓ | X | X | ✓ | X | + | ACLnoSx (vs ACLR Sx) may not change OA odds |
| Early ACLRc44 61 | 5–37 (266) | Phase I (1) Phase II (1) |
X | X | ✓ | X | ✓ | X | + | Early ACLRc (vs delayed or rehab only) may not change OA odds |
| Delayed ACLRc44 50 61 64 | 5–37 (438) | Phase I (3) Phase II (1) |
X | X | X | X | ✓ | X | + | Association of delayed ACLRc (vs early or no sx) and OA odds is unclear |
| ACL+meniscus sx74 | 32–37 (127) | Phase I (1) | X | Unclear | X | Unclear | ✓ | X | + | Association between ACL+meniscal sx (vs ACL only) and OA odds is unclear |
| ACLRc+meniscal sx (future)85 | 12 (103) | Phase II (1) | X | Unclear | X | ✓ | ✓ | ✓ | ++ | Association between ACLRc+meniscal sx (future) and OA odds is unclear |
| ACLRp42 48 50 55 | 2–30 (304) | Phase I (1) Phase II (3) |
XX | Unclear | ✓ | Unclear | ✓ | X | + | ACLRp (vs ACLRc) may not change OA odds |
| ACLRc approach47 | 12 (53) | Phase II (1) | ✓ | Unclear | ✓ | X | X | X | ++ | Association of ACLRc open (vs closed) and OA odds is unclear |
| ACLRc graft bundle number35 49 58 | 2–5 (624) | Phase II (3) | X | X | ✓ | X | ✓ | X | + | Double bundle allograft (vs single) may ↓ OA odds by 0.56 times |
| ACLRc graft type57 81 86 | 2–10 (587) | Phase I (1) Phase II (2) |
XX | X | ✓ | X | ✓ | X | + | Association of autograft (vs allo) and OA odds are unclear |
| Sx post-ACLRc62 | 15 (109) | Phase I (1) | XX | Unclear | X | Unclear | X | X | + | Association of sx post-ACLRc and OA odds is unclear |
| ACLRc revision79 | 8 (108) | Phase I (1) | XX | Unclear | ✓ | Unclear | X | X | + | Association of ACLRc revision and OA odds is unclear |
| Meniscal repair28 | 14 (62) | Phase I (1) | XX | Unclear | X | Unclear | ✓ | X | + | Association of meniscal repair and OA odds is unclear |
| Cartilage sx45 | 10 (57) | Phase II (1) | X | Unclear | ✓ | X | ✓ | X | ++ | Association of cartilage sx with OA odds is unclear |
| Anterior tibial motion74 76 78 82 91 94 | 7–37 (1193) | Phase I (6) | XX | Unclear | X | Unclear | X | X | + | Association of anterior tibial motion post-ACLRc and OA odds is unclear |
| Accessory TF motion38 82 | 7–14 (197) | Phase I (1) Phase II (1) |
XX | Unclear | ✓ | Unclear | Unclear | X | + | Association of accessory TF motion post-ACLRc and OA odds is unclear |
| AKP post-ACLRc77 | 20 (142) | Phase II (1) | ✓ | Unclear | X | X | ✓ | X | ++ | Association of AKP post-ACLRc with OA risk is unclear |
| Return to pivoting sport73 78 89 | 5–22 (473) | Phase I (2) Phase II (1) |
XX | ✓ | X | Unclear | ✓ | X | + | Association of return to pivoting sport with OA odds is unclear |
| TF ROM post-ACL or ACLRc29 69 74 91 94 | 7–37 (1035) | Phase I (4) Phase II (1) |
XX | ✓ | X | ✓ | ✓ | ✓ | + | Association of TF ROM post-ACL or ACLRc with OA odds is unclear |
| Hop post-ACL or ACLRc59 71 91 | 5–37 (425) | Phase I (4) | XX | Unclear | X | Unclear | X | ✓ | + | Association of hop function post-ACL or ACLRc and TF OA odds is unclear Asymmetry of hop function 4 years post-ACL may ↑ PF OA odds 5.1 times |
| Strength 4 years post-ACL tear74 | 32–37 (127) | Phase I (1) | X | Unclear | X | ✓ | ✓ | ✓ | + | Association of knee extension and flexion strength and OA odds is unclear |
| SR function post-ACL or ACLRc71 74 89 | 5–37 (421) | Phase I (2) Phase II (1) |
X | ✓ | X | Unclear | ✓ | X | + | Association of SR knee function post-ACL or ACLRc and OA odds is unclear |
| SR physical activity 4 years post-ACL74 | 32–37 (127) | Phase I (1) | X | Unclear | X | Unclear | ✓ | X | + | Association of physical activity post-ACL or ACLRc and OA odds is unclear |
| Proximal medial tibial angle75 | 10 (117) | Phase I (1) | X | Unclear | X | X | ✓ | X | + | Association of proximal medial tibial angle and OA odds is unclear |
| Anatomic axis angle75 | 10 (117) | Phase I (1) | X | Unclear | X | X | ✓ | X | + | Association of anatomic axis angle and OA odds is unclear |
| Inflammatory biomarkers63 | 16 (69) | Phase II (1) | X | Unclear | X | ✓ | ✓ | X | ++ | Association of assessed biomarkers and OA odds is unclear |
Bold: Factor(s) with moderate to high quality evidence and OR, or RR consistently positive (more than one analysis) with the largest estimate ≥2.0.
*Unclear (estimates significant in inconsistent directions), may (estimates mostly significant in the same direction or mostly not significant), increase or decrease (estimates consistently significant in the same direction).
++, low-certainty evidence; ✓, no limitations; ++++, high-certainty evidence; +, very low-certainty evidence; +++, moderate-certainty evidence; ACL, ACL tear; ACLnoSx, ACL tear with no sx; ACLRc, ACL reconstruction; ACLRp, ACL repair; AKP, anterior knee pain; CKS, Cincinnati Knee Score; GRADE, Grading of Recommendations Assessment, Development and Evaluation; MTF, medial tibiofemoral; n, number; OA, osteoarthritis; PFJ, patellofemoral joint; ROB, risk of bias; SR, self-reported; Sx, surgery; TF, tibiofemoral; x, time; X, serious limitations; XX, very serious limitations.
After assessing GRADE domains, there was moderate-certainty evidence that the risk of symptomatic OA was increased with cruciate ligament, collateral ligament, meniscal, chondral, tibiofemoral fractures, tibiofemoral or patellar (and recurrent) dislocations, and multistructure injuries (including patellar dislocations with chondral injuries). Further, there was moderate-certainty evidence that an ACL tear with any concomitant injury increases the odds of structural OA.
Discussion
There is moderate-certainty evidence that the risk of symptomatic knee OA was increased after various types of single (cruciate ligament, collateral ligament, meniscus, chondral, fracture or dislocation) and multistructure injuries (ACL with meniscal injuries, patellar dislocation with chondral injuries). There is also very-low certainty evidence that the odds of structural knee OA was increased after a cartilage injury (OR 2.31), partial meniscectomy (OR 1.87) and medial meniscectomy (OR 3.14) at ACLR. These findings clearly identify the target population for secondary prevention of symptomatic and structural post-traumatic OA as persons with a wide range of tibiofemoral and patellofemoral joint injuries with priority given to specific multistructure injuries (ACL tear with concomitant injury and patellofemoral dislocation with chondral defect). Unfortunately, no treatment targets for secondary prevention of symptomatic and structural post-traumatic OA were identified due to heterogeneity in potential risk factors assessed and comparator groups, high risk of bias and inconsistency in how potential risk factors and OA were defined, measured and analysed.
Based on very-low certainty evidence, we were able to estimate the magnitude of non-modifiable risk factors reported on narratively in a past systematic review,12 including increased odds of structural knee OA related to ACLR with cartilage injury (twofold), partial (twofold) or total (threefold) meniscectomy. Despite similarities in the direction of findings, the certainty of supporting evidence between our and the past review differ. This discrepancy may reflect differences in design, methods of assessing certainty of evidence, risk factor groupings, and distinction between symptomatic and structural OA across studies. Our findings are also consistent with Poulsen et al 99 who identified increased odds of radiographic, symptomatic or self-reported OA with ACL tears (fourfold), meniscal injuries (sixfold) or combined ACL tears and meniscal injuries (sixfold).
Building on these past reviews, we identified moderate-certainty evidence that the odds of symptomatic OA are elevated not only by ACL tears (with or without concomitant injuries), but with collateral ligament, meniscal, chondral, dislocations, fractures and multistructure injuries as well. Given that some non-ACL injuries (ie, collateral ligament injuries) have a similar prevalence as ACL tears and are associated with a fivefold increased risk of symptomatic OA at 11 years,97 it could be argued they are an important focus for primary (injury) prevention and that we need to expand our current paradigm about the ‘target population’ for secondary prevention. Finally, we identified that male sex at ACL tear, older age at ACLR, higher BMI at ACLR, rehabilitation for ACL tear, ACLR for ACL tear, ACLR autograph choice, and ACLR augmentation do not change the odds of structural OA.
An important finding of this review is the high risk of bias that exists in the evidence-base underpinning prognosis after knee trauma, particularly in relation to attrition (selection bias) and controlling for confounding. Contributing to this are the large number of exploratory studies aimed at ‘identifying associations’ between a mosaic of potential risk factors and an equally diverse set of possible outcomes (one of which is OA). Typically, these studies do not account for confounding or multiple comparisons and only report p values or estimates of OA when the relationship is statistically significant (ie, reporting bias). Another common limitation saturating the evidence-base is the interpretation of coefficients included in regression models to control for potential confounding as if they were the primary risk factor of interest.100
From year 2000 to present, there appears to have been improvements (table 1) in reporting and reducing measurement bias for outcome variables, bias in statistical analysis and bias in confounding. Despite this, risk of bias related to participant attrition and its reporting persist. Transparent reporting of attrition is vital to ensure that future studies to confirm or explain the relationship between a risk factor and OA are adequately powered to detect changes at distant time points. Disguising attrition rates, or the forces driving attrition, only serves to weaken the field of study.
Recommendations for future research
The inability to identify treatment targets (modifiable risk factors) for preventing symptomatic knee OA after trauma, despite the extensive resources invested in the 66 studies included in this review, is nothing short of depressing. There is an urgent need to move beyond studies that ‘explore or identify’ the relationship between potential risk factors and structural OA, towards studies specifically designed to test independent associations between a risk factor and symptomatic OA, or explain the prognostic pathway with adequately powered statistical models built around the primary risk factor of interest. This might be best facilitated by involving an epidemiologist and/or a statistician. It is also important to recognise that unlike non-modifiable risk factors, high-certainty evidence for a modifiable risk factor can only come from an RCT (or meta-analyses of RCTs) showing that an intervention capable of modifying the risk factor reduces the incidence of OA.
Fewer than 25% of the included studies assessed risk factors for symptomatic OA. Given that it is the pain, disability and loss of quality of life associated with OA that drive the substantial personal and societal burden (healthcare use and workforce disability) of this condition, it is vital that future studies look beyond structural (ie, radiographic) definitions and focus on the ‘illness’ of OA. Similarly, only 13% of the studies we identified considered knee injuries beyond ACL tears. A broader consideration of traumatic knee injury, beyond ACL tear is needed to understand how to best tailor prevention strategies.
Despite identifying >80 unique potential risk factors, there was an obvious paucity of socioeconomic (eg, education and literacy, employment status, income, access to health services), sociocultural (eg, ethnicity, gender, childhood experiences) and ecological (eg, physical environment, climate, population density) factors in the evidence-base. As many of these factors are known determinants of health, it is reasonable they may influence the development of symptomatic OA after knee trauma and should be prioritised.
Given the challenges of retaining participants over many years, it is essential that future studies adjust for realistic attrition ‘a priori’. Similarly, there is an urgent need for consensus on definitions of early (in the lifespan) symptomatic and structural OA, early-stage (in the course of the illness/disease) symptomatic and structural OA,101 and how to operationalise, measure and handle key modifiable risk factors to enable future meta-analyses. Consensus on OA definitions102 and important modifiable risk factors are also needed to facilitate their inclusion in administrative datasets to allow for population level analyses.
Methodological (PROGRESS 2)11 and reporting (CONSORT,103 STROBE)104 guidelines exist and should be consulted during future study design. When reported, structural OA should be evaluated and presented for the total knee complex and for individual tibiofemoral and patellofemoral compartments to facilitate more precise data pooling. Particular attention should be paid to best practice for dealing with missing data, reporting selection bias (comparison of those lost to follow-up to those retained) and not categorising continuous variables in arbitrary, uninformative groupings. Presenting data in interpretable figures, including frequency with a denominator, and online supplemental files will facilitate future meta-analyses.
Clinical implications
Efforts to prevent symptomatic and structural OA after knee trauma should target people with a wide range of single and multistructure tibiofemoral and patellofemoral joint injuries. Although no clear treatment targets for preventing symptomatic or structural knee OA after knee trauma exist, efforts to reduce the burden of post-traumatic knee OA should not be abandoned. A logical and pragmatic approach would be to implement evidence-based injury prevention programmes to reduce the incidence of all knee trauma and target known independent modifiable risk factors for knee OA in general (as they will likely compound risk after trauma) following a wide range of knee injuries (not just ACL tears).6 105 This should include physical activity and exercise-therapy strategies to minimise unhealthy adiposity106–108 and quadriceps weakness.109
Another important clinical implication of this review relates to managing expectations about potential risk factors commonly cited as having either a protective or harmful effect for post-traumatic knee OA where evidence suggests otherwise. For example, the perceived value of early ACLR for reducing the risk for OA, and perceived harmful effect of late ACLR,110 rehabilitation only, or returning to pivoting sports after ACL tear.111
Strengths and limitations
Every effort was made to follow best practice for systematic reviews and meta-analyses for prognostic factors, and grading risk of bias and certainty of evidence. We developed a comprehensive search strategy in consultation with a librarian scientist and performed extensive searches without limiting the types of potential risk factors or knee injuries included. These efforts resulted in the most extensive synthesis, analysis (quantitative and qualitative) and presentation of potential risk factors for OA after knee trauma to date.
We acknowledge that our meta-analyses combined data across a range of follow-up times with significant heterogeneity. By including data from early timepoints when structural changes and/or symptoms are less prevalent, it is possible that the odds of OA are underestimated. With respect to heterogeneity, we have been transparent about the source and based our interpretations on 95% CI, not p values. Despite an ‘a priori’ decision tree, discussing unforeseen decisions among the research team, our semiquantitative synthesis is dependent on the judgement of the research team and prone to investigator bias. This may have resulted in more downgrading of evidence in an attempt to avoid overstating findings without supporting quantitative estimates. In contrast, the conservative nature of our QUIPS signalling questions and criteria for semiquantitative application of GRADE may have elevated the certainty of evidence ratings. Although we excluded studies published prior to 2000, some of the procedures (ie, ACL tear diagnosis with arthroscopy, open ACLR, ACL repair, total meniscectomy, prolonged knee immobilisation) in studies with longer follow-up periods are not common today and may have influenced the odds of OA. Finally, despite attempts to group studies into similar treatment groups, heterogeneity (ie, ACLR, ACL repair with or without augmentation) within samples must be acknowledged.
Conclusion
There is moderate certainty of evidence that the risk of symptomatic knee OA is increased after various single and multistructure knee injuries. Similarly, there is very-low certainty evidence that the odds of structural OA is increased with cartilage injury, partial meniscectomy and medial meniscectomy at ACLR. In contrast, no modifiable risk factors, or treatment targets, for symptomatic or structural knee OA after knee trauma were identified. Consensus on how to operationalise and handle potential risk factors, comparator groups and osteoarthritis are needed to inform strategies to prevent post-traumatic knee OA.
Acknowledgments
JLW is supported by a Michael Smith Foundation for Health Research a Scholar Award (SCH-2020-0403) and an Arthritis Society STAR Career Development Award (STAR-19-0493). JML is supported by the Arthritis Society. LKT is supported by a Canadian Institutes of Health Research Fellowship. AGC is supported by a National Health and Medical Research Council (NHMRC) of Australia Investigator Grant (GNT2008523). The authors would like to acknowledge librarian scientist Wichor M. Bramer, PhD (Erasmus MC) who performed the database searches, librarian scientist Charlotte Beck (UBC) who assisted in translating the MEDLINE search strategy into SPORTDiscus and other OPTIKNEE review leads Bjørnar Berg, Stephanie Filbay, Pætur Holm, Erin Macri, Britt Elin Øiestad, May Arna Risberg, and Anouk Urhausen for their methodological input.
Footnotes
Twitter: @jwhittak_physio, @JayLos18, @jbthorlund, @LKTphysio, @bellevanmeer, @agculvenor, @ewa_roos, @mvanmiddelkoop
Contributors: AGC, JLW, ER and KMC were involved in priority theme setting. JLW coordinated the study. JLW, MvM, KMC, AGC, ER, JBT, CBJ, LKT, MM and BvM were involved in the design of the study. JLW, MvM, JML, JBT, LKT and BvM screened title and abstracts as well as full-text records. JLW, JML, JBT, LKT, MvM and ML performed data extraction and risk of bias assessment. MM contributed their lived experience to the design of (risk factors of interest), conduct (data extraction-author, year, country of publication, sample characteristics), and write-up (identification of key messages such as a focus on symptomatic versus structural OA). JLW and JML performed statistical analysis in conjunction with CBJ. JLW and JML wrote the first draft of the manuscript. All authors contributed to reviewing, editing and revising the manuscript and approved the final submitted version. JLW is the guarantor.
Funding: Initial priority theme setting for the OPTIKNEE consensus (https://bit.ly/OPTIKNEE) was supported by a Canadian Institutes of Health Research Planning and Dissemination Grant (principal investigator JLW #161821) and a La Trobe University Research Focus Area Collaboration Grant (principal investigator AGC). The funders had no role in any part of the study or in any decision about publication.
Competing interests: JLW and AGC are associate editors of the British Journal of Sports Medicine (BJSM). JLW is an editor with the Journal of Orthopaedic and Sports Physical Therapy. KMC is a senior advisor of BJSM, project leader of the Good Life with Osteoarthritis from Denmark (GLA:D) – Australia a not-for profit initiative to implement clinical guidelines in primary care, and holds a research grant from Levin Health outside the submitted work. CBJ an associate editor of Osteoarthritis and Cartilage. JBT holds a research grant from Pfizer outside the submitted work. ER is deputy editor of Osteoarthritis and Cartilage, developer of Knee injury and Osteoarthritis Outcome Score (KOOS) and several other freely available patient-reported outcome measures, and founder of the GLA:D). All other authors declare no competing interests.
Provenance and peer review: Not commissioned; externally peer reviewed.
Supplemental material: This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.
Ethics statements
Patient consent for publication
Not applicable.
Ethics approval
Not applicable.
References
- 1. Cross M, Smith E, Hoy D, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 2014;73:1323–30. 10.1136/annrheumdis-2013-204763 [DOI] [PubMed] [Google Scholar]
- 2. Safiri S, Kolahi A-A, Smith E, et al. Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the global burden of disease study 2017. Ann Rheum Dis 2020;79:819–28. 10.1136/annrheumdis-2019-216515 [DOI] [PubMed] [Google Scholar]
- 3. Yu D, Jordan KP, Bedson J, et al. Population trends in the incidence and initial management of osteoarthritis: age-period-cohort analysis of the clinical practice research Datalink, 1992-2013. Rheumatology 2017;56:1902–17. 10.1093/rheumatology/kex270 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Clin Geriatr Med 2010;26:355–69. 10.1016/j.cger.2010.03.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Roos EM, Arden NK. Strategies for the prevention of knee osteoarthritis. Nat Rev Rheumatol 2016;12:92–101. 10.1038/nrrheum.2015.135 [DOI] [PubMed] [Google Scholar]
- 6. Whittaker JL, Runhaar J, Bierma-Zeinstra S, et al. A lifespan approach to osteoarthritis prevention. Osteoarthritis Cartilage 2021;29:1638-1653. 10.1016/j.joca.2021.06.015 [DOI] [PubMed] [Google Scholar]
- 7. Emery CA, Roy T-O, Whittaker JL, et al. Neuromuscular training injury prevention strategies in youth sport: a systematic review and meta-analysis. Br J Sports Med 2015;49:865–70. 10.1136/bjsports-2015-094639 [DOI] [PubMed] [Google Scholar]
- 8. Fransen M, McConnell S, Harmer AR, et al. Exercise for osteoarthritis of the knee: a Cochrane systematic review. Br J Sports Med 2015;49:1554–7. 10.1136/bjsports-2015-095424 [DOI] [PubMed] [Google Scholar]
- 9. Allen KD, Choong PF, Davis AM, et al. Osteoarthritis: models for appropriate care across the disease continuum. Best Pract Res Clin Rheumatol 2016;30:503–35. 10.1016/j.berh.2016.09.003 [DOI] [PubMed] [Google Scholar]
- 10. Runhaar J, Zhang Y. Can we prevent OA? Epidemiology and public health insights and implications. Rheumatology 2018;57:iv3–9. 10.1093/rheumatology/key014 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Riley RD, Hayden JA, Steyerberg EW, et al. Prognosis research strategy (progress) 2: prognostic factor research. PLoS Med 2013;10:e1001380. 10.1371/journal.pmed.1001380 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. van Meer BL, Meuffels DE, van Eijsden WA, et al. Which determinants predict tibiofemoral and patellofemoral osteoarthritis after anterior cruciate ligament injury? A systematic review. Br J Sports Med 2015;49:975–83. 10.1136/bjsports-2013-093258 [DOI] [PubMed] [Google Scholar]
- 13.et alHiggins JPT, Thomas J, Chandler J. Cochrane Handbook for systematic reviews of interventions, 2019. Available: www.training.cochrane.org/handbook
- 14. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. 10.1136/bmj.n71 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Rethlefsen ML, Kirtley S, Waffenschmidt S, et al. PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews. Syst Rev 2021;10:39. 10.1186/s13643-020-01542-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Zhang W, Doherty M, Peat G, et al. EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis. Ann Rheum Dis 2010;69:483–9. 10.1136/ard.2009.113100 [DOI] [PubMed] [Google Scholar]
- 17. Altman R, Asch E, Bloch D. Development of criteria for the classification and reporting of osteoarthritis. classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986;29:1039–49. [DOI] [PubMed] [Google Scholar]
- 18. National Institute of Health Care Excellence . Osteoarthritis: care and management in adults. 2014, 2014. Available: https://ard.bmj.com/content/69/3/483 [PubMed]
- 19. Jones MH, Spindler KP, Fleming BC, et al. Meniscus treatment and age associated with narrower radiographic joint space width 2-3 years after ACL reconstruction: data from the moon onsite cohort. Osteoarthritis Cartilage 2015;23:581–8. 10.1016/j.joca.2014.12.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Thorlund JB, Østengaard L, Cardy N, et al. Trajectory of self-reported pain and function and knee extensor muscle strength in young patients undergoing arthroscopic surgery for meniscal tears: a systematic review and meta-analysis. J Sci Med Sport 2017;20:712–7. 10.1016/j.jsams.2017.02.004 [DOI] [PubMed] [Google Scholar]
- 21. Riley RD, Moons KGM, Snell KIE, et al. A guide to systematic review and meta-analysis of prognostic factor studies. BMJ 2019;364:k4597. 10.1136/bmj.k4597 [DOI] [PubMed] [Google Scholar]
- 22. Hayden JA, van der Windt DA, Cartwright JL, et al. Assessing bias in studies of prognostic factors. Ann Intern Med 2013;158:280–6. 10.7326/0003-4819-158-4-201302190-00009 [DOI] [PubMed] [Google Scholar]
- 23. Teirlinck CH, Dorleijn DMJ, Bos PK. Prognostic factors for progression of osteoarthritis of the hip: a systematic review. Arthritis Research and Therapy 2019;21:1–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Grooten WJA, Tseli E, Äng BO, et al. Elaborating on the assessment of the risk of bias in prognostic studies in pain rehabilitation using QUIPS-aspects of interrater agreement. Diagn Progn Res 2019;3:5. 10.1186/s41512-019-0050-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Sterne JAC, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009;338:b2393. 10.1136/bmj.b2393 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Brandt KD, Fife RS, Braunstein EM, et al. Radiographic grading of the severity of knee osteoarthritis: relation of the Kellgren and Lawrence grade to a grade based on joint space narrowing, and correlation with arthroscopic evidence of articular cartilage degeneration. Arthritis Rheum 1991;34:1381–6. 10.1002/art.1780341106 [DOI] [PubMed] [Google Scholar]
- 27. Petersson IF, Boegård T, Saxne T, et al. Radiographic osteoarthritis of the knee classified by the Ahlbäck and Kellgren & Lawrence systems for the tibiofemoral joint in people aged 35-54 years with chronic knee pain. Ann Rheum Dis 1997;56:493–6. 10.1136/ard.56.8.493 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Rockborn P, Gillquist J. Results of open meniscus repair. long-term follow-up study with a matched uninjured control group. J Bone Joint Surg Br 2000;82:494–8. 10.1302/0301-620x.82b4.9942 [DOI] [PubMed] [Google Scholar]
- 29. Shelbourne KD, Urch SE, Gray T, et al. Loss of normal knee motion after anterior cruciate ligament reconstruction is associated with radiographic arthritic changes after surgery. Am J Sports Med 2012;40:108–13. 10.1177/0363546511423639 [DOI] [PubMed] [Google Scholar]
- 30. Huguet A, Hayden JA, Stinson J, et al. Judging the quality of evidence in reviews of prognostic factor research: adapting the grade framework. Syst Rev 2013;2:71. 10.1186/2046-4053-2-71 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Higgins JPT, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557–60. 10.1136/bmj.327.7414.557 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539–58. 10.1002/sim.1186 [DOI] [PubMed] [Google Scholar]
- 33. Hayden JA, Côté P, Steenstra IA, et al. Identifying phases of investigation helps planning, appraising, and applying the results of explanatory prognosis studies. J Clin Epidemiol 2008;61:552–60. 10.1016/j.jclinepi.2007.08.005 [DOI] [PubMed] [Google Scholar]
- 34. Nüesch E, Trelle S, Reichenbach S, et al. Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study. BMJ 2010;341:c3515. 10.1136/bmj.c3515 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Aga C, Risberg MA, Fagerland MW, et al. No difference in the KOOS quality of life Subscore between anatomic Double-Bundle and anatomic Single-Bundle anterior cruciate ligament reconstruction of the knee: a prospective randomized controlled trial with 2 years' follow-up. Am J Sports Med 2018;46:2341–54. 10.1177/0363546518782454 [DOI] [PubMed] [Google Scholar]
- 36. Ahldén M, Kartus J, Ejerhed L, et al. Knee laxity measurements after anterior cruciate ligament reconstruction, using either bone-patellar-tendon-bone or hamstring tendon autografts, with special emphasis on comparison over time. Knee Surg Sports Traumatol Arthrosc 2009;17:1117–24. 10.1007/s00167-009-0846-5 [DOI] [PubMed] [Google Scholar]
- 37. Akelman MR, Fadale PD, Hulstyn MJ, et al. Effect of matching or Overconstraining knee laxity during anterior cruciate ligament reconstruction on knee osteoarthritis and clinical outcomes: a randomized controlled trial with 84-Month follow-up. Am J Sports Med 2016;44:1660–70. 10.1177/0363546516638387 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Barenius B, Ponzer S, Shalabi A, et al. Increased risk of osteoarthritis after anterior cruciate ligament reconstruction: a 14-year follow-up study of a randomized controlled trial. Am J Sports Med 2014;42:1049–57. 10.1177/0363546514526139 [DOI] [PubMed] [Google Scholar]
- 39. Björnsson H, Samuelsson K, Sundemo D, et al. A randomized controlled trial with mean 16-year follow-up comparing hamstring and patellar tendon autografts in anterior cruciate ligament reconstruction. Am J Sports Med 2016;44:2304–13. 10.1177/0363546516646378 [DOI] [PubMed] [Google Scholar]
- 40. Castoldi M, Magnussen RA, Gunst S, et al. A randomized controlled trial of Bone-Patellar Tendon-Bone anterior cruciate ligament reconstruction with and without lateral extra-articular Tenodesis: 19-year clinical and radiological follow-up. Am J Sports Med 2020;48:1665–72. 10.1177/0363546520914936 [DOI] [PubMed] [Google Scholar]
- 41. Drogset JO, Grøntvedt T. Anterior cruciate ligament reconstruction with and without a ligament augmentation device : results at 8-Year follow-up. Am J Sports Med 2002;30:851–6. 10.1177/03635465020300061601 [DOI] [PubMed] [Google Scholar]
- 42. Drogset JO, Grøntvedt T, Robak OR, et al. A sixteen-year follow-up of three operative techniques for the treatment of acute ruptures of the anterior cruciate ligament. The Journal of Bone & Joint Surgery 2006;88:944–52. 10.2106/JBJS.D.02876 [DOI] [PubMed] [Google Scholar]
- 43. Elveos MM, Drogset JO, Engebretsen L, et al. Anterior cruciate ligament reconstruction using a Bone-Patellar Tendon-Bone graft with and without a ligament augmentation device: a 25-year follow-up of a prospective randomized controlled trial. Orthop J Sports Med 2018;6:2325967118808778. 10.1177/2325967118808778 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Frobell RB, Roos HP, Roos EM, et al. Treatment for acute anterior cruciate ligament tear: five year outcome of randomised trial. BMJ 2013;346:f232–f32. 10.1136/bmj.f232 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Gudas R, Gudaitė A, Pocius A, et al. Ten-Year follow-up of a prospective, randomized clinical study of mosaic osteochondral autologous transplantation versus microfracture for the treatment of osteochondral defects in the knee joint of athletes. Am J Sports Med 2012;40:2499–508. 10.1177/0363546512458763 [DOI] [PubMed] [Google Scholar]
- 46. Holm I, Øiestad BE, Risberg MA, et al. No difference in knee function or prevalence of osteoarthritis after reconstruction of the anterior cruciate ligament with 4-strand hamstring autograft versus patellar tendon-bone autograft: a randomized study with 10-year follow-up. Am J Sports Med 2010;38:448–54. 10.1177/0363546509350301 [DOI] [PubMed] [Google Scholar]
- 47. Holm I, Øiestad BE, Risberg MA, et al. No differences in prevalence of osteoarthritis or function after open versus endoscopic technique for anterior cruciate ligament reconstruction: 12-year follow-up report of a randomized controlled trial. Am J Sports Med 2012;40:2492–8. 10.1177/0363546512458766 [DOI] [PubMed] [Google Scholar]
- 48. Hoogeslag RAG, Brouwer RW, Boer BC, et al. Acute anterior cruciate ligament rupture: repair or reconstruction? two-year results of a randomized controlled clinical trial. Am J Sports Med 2019;47:567–77. 10.1177/0363546519825878 [DOI] [PubMed] [Google Scholar]
- 49. Karikis I, Desai N, Sernert N. Comparison of anatomic double- and Single-Bundle techniques for anterior cruciate ligament reconstruction using hamstring tendon autografts. American Journal of Sports Medicine 2016;44:1225–36. [DOI] [PubMed] [Google Scholar]
- 50. Meunier A, Odensten M, Good L. Long-Term results after primary repair or non-surgical treatment of anterior cruciate ligament rupture: a randomized study with a 15-year follow-up. Scand J Med Sci Sports 2007;17:230–7. 10.1111/j.1600-0838.2006.00547.x [DOI] [PubMed] [Google Scholar]
- 51. Sajovic M, Stropnik D, Skaza K. Long-Term comparison of semitendinosus and gracilis tendon versus patellar tendon autografts for anterior cruciate ligament reconstruction: a 17-year follow-up of a randomized controlled trial. Am J Sports Med 2018;46:1800–8. 10.1177/0363546518768768 [DOI] [PubMed] [Google Scholar]
- 52. Sajovic M, Vengust V, Komadina R, et al. A prospective, randomized comparison of semitendinosus and gracilis tendon versus patellar tendon autografts for anterior cruciate ligament reconstruction: five-year follow-up. Am J Sports Med 2006;34:1933–40. 10.1177/0363546506290726 [DOI] [PubMed] [Google Scholar]
- 53. Sajovic M, Strahovnik A, Dernovsek MZ, et al. Quality of life and clinical outcome comparison of semitendinosus and gracilis tendon versus patellar tendon autografts for anterior cruciate ligament reconstruction: an 11-year follow-up of a randomized controlled trial. Am J Sports Med 2011;39:2161–9. 10.1177/0363546511411702 [DOI] [PubMed] [Google Scholar]
- 54. Hamrin Senorski E, Sundemo D, Svantesson E, et al. Preoperative and intraoperative predictors of long-term acceptable knee function and osteoarthritis after anterior cruciate ligament reconstruction: an analysis based on 2 randomized controlled trials. Arthroscopy 2019;35:489–99. 10.1016/j.arthro.2018.07.009 [DOI] [PubMed] [Google Scholar]
- 55. Sporsheim AN, Gifstad T, Lundemo TO, et al. Autologous BPTB ACL reconstruction results in lower failure rates than ACL repair with and without synthetic augmentation at 30 years of follow-up. J Bone Joint Surg 2019;101:2074–81. 10.2106/JBJS.19.00098 [DOI] [PubMed] [Google Scholar]
- 56. Webster KE, Feller JA, Hartnett N, et al. Comparison of Patellar tendon and hamstring tendon anterior cruciate ligament reconstruction. Am J Sports Med 2016;44:83–90. 10.1177/0363546515611886 [DOI] [PubMed] [Google Scholar]
- 57. Yoo S-H, Song E-K, Shin Y-R. Comparison of clinical outcomes and second-look arthroscopic findings after ACL reconstruction using a hamstring autograft or a tibialis allograft. Knee Surgery, Sports Traumatology, Arthroscopy 2017;25:1290–7. [DOI] [PubMed] [Google Scholar]
- 58. Sun R, Chen B-cheng, Wang F, et al. Prospective randomized comparison of knee stability and joint degeneration for double- and single-bundle ACL reconstruction. Knee Surg Sports Traumatol Arthrosc 2015;23:1171–8. 10.1007/s00167-014-2934-4 [DOI] [PubMed] [Google Scholar]
- 59. Janssen RPA, du Mée AWF, van Valkenburg J, et al. Anterior cruciate ligament reconstruction with 4-strand hamstring autograft and accelerated rehabilitation: a 10-year prospective study on clinical results, knee osteoarthritis and its predictors. Knee Surg Sports Traumatol Arthrosc 2013;21:1977–88. 10.1007/s00167-012-2234-9 [DOI] [PubMed] [Google Scholar]
- 60. Johnson VL, Roe JP, Salmon LJ, et al. Does age influence the risk of incident knee osteoarthritis after a traumatic anterior cruciate ligament injury? Am J Sports Med 2016;44:2399–405. 10.1177/0363546516648318 [DOI] [PubMed] [Google Scholar]
- 61. Kvist J, Filbay S, Andersson C, et al. Radiographic and symptomatic knee osteoarthritis 32 to 37 years after acute anterior cruciate ligament rupture. Am J Sports Med 2020;48:2387–94. 10.1177/0363546520939897 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Leys T, Salmon L, Waller A, et al. Clinical results and risk factors for reinjury 15 years after anterior cruciate ligament reconstruction: a prospective study of hamstring and patellar tendon grafts. Am J Sports Med 2012;40:595–605. 10.1177/0363546511430375 [DOI] [PubMed] [Google Scholar]
- 63. Neuman P, Dahlberg LE, Englund M, et al. Concentrations of synovial fluid biomarkers and the prediction of knee osteoarthritis 16 years after anterior cruciate ligament injury. Osteoarthritis Cartilage 2017;25:492–8. 10.1016/j.joca.2016.09.008 [DOI] [PubMed] [Google Scholar]
- 64. Neuman P, Englund M, Kostogiannis I, et al. Prevalence of tibiofemoral osteoarthritis 15 years after nonoperative treatment of anterior cruciate ligament injury: a prospective cohort study. Am J Sports Med 2008;36:1717–25. 10.1177/0363546508316770 [DOI] [PubMed] [Google Scholar]
- 65. Øiestad BE, Holm I, Aune AK, et al. Knee function and prevalence of knee osteoarthritis after anterior cruciate ligament reconstruction: a prospective study with 10 to 15 years of follow-up. Am J Sports Med 2010;38:2201–10. 10.1177/0363546510373876 [DOI] [PubMed] [Google Scholar]
- 66. Øiestad BE, Holm I, Gunderson R, et al. Quadriceps muscle weakness after anterior cruciate ligament reconstruction: a risk factor for knee osteoarthritis? Arthritis Care Res 2010;62:1706–14. 10.1002/acr.20299 [DOI] [PubMed] [Google Scholar]
- 67. Risberg MA, Oiestad BE, Gunderson R, et al. Changes in knee osteoarthritis, symptoms, and function after anterior cruciate ligament reconstruction: a 20-year prospective follow-up study. Am J Sports Med 2016;44:1215–24. 10.1177/0363546515626539 [DOI] [PubMed] [Google Scholar]
- 68. Shelbourne KD, Benner RW, Nixon RA, et al. Evaluation of peripheral vertical nondegenerative medial meniscus tears treated with trephination alone at the time of anterior cruciate ligament reconstruction. Arthroscopy 2015;31:2411–6. 10.1016/j.arthro.2015.06.024 [DOI] [PubMed] [Google Scholar]
- 69. Shelbourne KD, Benner RW, Gray T. Results of anterior cruciate ligament reconstruction with patellar tendon autografts: objective factors associated with the development of osteoarthritis at 20 to 33 years after surgery. Am J Sports Med 2017;45:2730–8. 10.1177/0363546517718827 [DOI] [PubMed] [Google Scholar]
- 70. Ulstein S, Bredland K, Årøen A, et al. No negative effect on patient-reported outcome of concomitant cartilage lesions 5-9 years after ACL reconstruction. Knee Surg Sports Traumatol Arthrosc 2017;25:1482–8. 10.1007/s00167-016-4163-5 [DOI] [PubMed] [Google Scholar]
- 71. Wellsandt E, Axe MJ, Snyder-Mackler L. Poor performance on Single-Legged hop tests associated with development of posttraumatic knee osteoarthritis after anterior cruciate ligament injury. Orthop J Sports Med 2018;6:2325967118810775. 10.1177/2325967118810775 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72. Whittaker JL, Toomey CM, Woodhouse LJ, et al. Association between MRI-defined osteoarthritis, pain, function and strength 3-10 years following knee joint injury in youth sport. Br J Sports Med 2018;52:934–9. 10.1136/bjsports-2017-097576 [DOI] [PubMed] [Google Scholar]
- 73. Haberfield MJ, Patterson BE, Crossley KM, et al. Should return to pivoting sport be avoided for the secondary prevention of osteoarthritis after anterior cruciate ligament reconstruction? A prospective cohort study with MRI, radiographic and symptomatic outcomes. Osteoarthritis Cartilage 2021;29:1673-1681. 10.1016/j.joca.2021.04.003 [DOI] [PubMed] [Google Scholar]
- 74. Filbay S, Gauffin H, Andersson C, et al. Prognostic factors for tibiofemoral and patellofemoral osteoarthritis 32-37 years after anterior cruciate ligament injury managed with early surgical repair or rehabilitation alone. Osteoarthritis Cartilage 2021;29:1682-1690. 10.1016/j.joca.2021.08.009 [DOI] [PubMed] [Google Scholar]
- 75. Ahn JH, Kim JG, Wang JH, et al. Long-Term results of anterior cruciate ligament reconstruction using bone-patellar tendon-bone: an analysis of the factors affecting the development of osteoarthritis. Arthroscopy 2012;28:1114–23. 10.1016/j.arthro.2011.12.019 [DOI] [PubMed] [Google Scholar]
- 76. Cantin O, Lustig S, Rongieras F, et al. Outcome of cartilage at 12years of follow-up after anterior cruciate ligament reconstruction. Orthop Traumatol Surg Res 2016;102:857–61. 10.1016/j.otsr.2016.06.011 [DOI] [PubMed] [Google Scholar]
- 77. Culvenor AG, Øiestad BE, Holm I, et al. Anterior knee pain following anterior cruciate ligament reconstruction does not increase the risk of patellofemoral osteoarthritis at 15- and 20-year follow-ups. Osteoarthritis Cartilage 2017;25:30–3. 10.1016/j.joca.2016.09.012 [DOI] [PubMed] [Google Scholar]
- 78. Curado J, Hulet C, Hardy P, et al. Very long-term osteoarthritis rate after anterior cruciate ligament reconstruction: 182 cases with 22-year' follow-up. Orthop Traumatol Surg Res 2020;106:459–63. 10.1016/j.otsr.2019.09.034 [DOI] [PubMed] [Google Scholar]
- 79. Gifstad T, Drogset JO, Viset A, et al. Inferior results after revision ACL reconstructions: a comparison with primary ACL reconstructions. Knee Surg Sports Traumatol Arthrosc 2013;21:2011–8. 10.1007/s00167-012-2336-4 [DOI] [PubMed] [Google Scholar]
- 80. Hagmeijer MH, Hevesi M, Desai VS, et al. Secondary meniscal tears in patients with anterior cruciate ligament injury: relationship among operative management, osteoarthritis, and arthroplasty at 18-year mean follow-up. Am J Sports Med 2019;47:1583–90. 10.1177/0363546519844481 [DOI] [PubMed] [Google Scholar]
- 81., Jones MH, Oak SR, et al. , MOON Knee Group . Predictors of radiographic osteoarthritis 2 to 3 years after anterior cruciate ligament reconstruction: data from the moon on-site nested cohort. Orthop J Sports Med 2019;7:2325967119867085. 10.1177/2325967119867085 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82. Jonsson H, Riklund-Ahlström K, Lind J. Positive pivot shift after ACL reconstruction predicts later osteoarthrosis: 63 patients followed 5-9 years after surgery. Acta Orthop Scand 2004;75:594–9. 10.1080/00016470410001484 [DOI] [PubMed] [Google Scholar]
- 83. Kessler MA, Behrend H, Henz S, et al. Function, osteoarthritis and activity after ACL-rupture: 11 years follow-up results of conservative versus reconstructive treatment. Knee Surg Sports Traumatol Arthrosc 2008;16:442–8. 10.1007/s00167-008-0498-x [DOI] [PubMed] [Google Scholar]
- 84. Li RT, Lorenz S, Xu Y, et al. Predictors of radiographic knee osteoarthritis after anterior cruciate ligament reconstruction. Am J Sports Med 2011;39:2595–603. 10.1177/0363546511424720 [DOI] [PubMed] [Google Scholar]
- 85. Lohmander LS, Ostenberg A, Englund M, et al. High prevalence of knee osteoarthritis, pain, and functional limitations in female soccer players twelve years after anterior cruciate ligament injury. Arthritis Rheum 2004;50:3145–52. 10.1002/art.20589 [DOI] [PubMed] [Google Scholar]
- 86. Mascarenhas R, Tranovich M, Karpie JC, et al. Patellar tendon anterior cruciate ligament reconstruction in the high-demand patient: evaluation of autograft versus allograft reconstruction. Arthroscopy 2010;26:S58–66. 10.1016/j.arthro.2010.01.004 [DOI] [PubMed] [Google Scholar]
- 87. Meuffels DE, Favejee MM, Vissers MM, et al. Ten year follow-up study comparing conservative versus operative treatment of anterior cruciate ligament ruptures. A matched-pair analysis of high level athletes. Br J Sports Med 2009;43:347–51. 10.1136/bjsm.2008.049403 [DOI] [PubMed] [Google Scholar]
- 88. Nordenvall R, Bahmanyar S, Adami J, et al. Cruciate ligament reconstruction and risk of knee osteoarthritis: the association between cruciate ligament injury and post-traumatic osteoarthritis. A population based nationwide study in Sweden, 1987-2009. PLoS One 2014;9:e104681. 10.1371/journal.pone.0104681 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89. Øiestad BE, Holm I, Risberg MA. Return to pivoting sport after ACL reconstruction: association with osteoarthritis and knee function at the 15-year follow-up. Br J Sports Med 2018;52:1199–204. [DOI] [PubMed] [Google Scholar]
- 90. Persson F, Turkiewicz A, Bergkvist D, et al. The risk of symptomatic knee osteoarthritis after arthroscopic meniscus repair vs partial meniscectomy vs the general population. Osteoarthritis Cartilage 2018;26:195–201. 10.1016/j.joca.2017.08.020 [DOI] [PubMed] [Google Scholar]
- 91. Pinczewski LA, Lyman J, Salmon LJ, et al. A 10-year comparison of anterior cruciate ligament reconstructions with hamstring tendon and patellar tendon autograft: a controlled, prospective trial. Am J Sports Med 2007;35:564–74. 10.1177/0363546506296042 [DOI] [PubMed] [Google Scholar]
- 92. Pinczewski LA, Deehan DJ, Salmon LJ. A five-year comparison of patellar tendon versus four-strand hamstring tendon autograft for arthroscopic reconstruction of the anterior cruciate ligament. / Comparaison, pendant cinq ans, de l ' utilisation de l ' autogreffe du tendon rotulien par rapport. American Journal of Sports Medicine 2002;30:523–36. [DOI] [PubMed] [Google Scholar]
- 93. Rhon DI, Perez KG, Eskridge SL. Risk of post-traumatic knee osteoarthritis after knee injury in military service members. Musculoskeletal Care 2019;17:113–9. 10.1002/msc.1378 [DOI] [PubMed] [Google Scholar]
- 94. Roe J, Pinczewski LA, Russell VJ, et al. A 7-year follow-up of Patellar tendon and hamstring tendon grafts for arthroscopic anterior cruciate ligament reconstruction: differences and similarities. Am J Sports Med 2005;33:1337–45. 10.1177/0363546504274145 [DOI] [PubMed] [Google Scholar]
- 95. Sanders TL, Kremers HM, Bryan AJ, et al. Is anterior cruciate ligament reconstruction effective in preventing secondary meniscal tears and osteoarthritis? Am J Sports Med 2016;44:1699–707. 10.1177/0363546516634325 [DOI] [PubMed] [Google Scholar]
- 96. Sanders TL, Pareek A, Johnson NR, et al. Patellofemoral arthritis after lateral patellar dislocation: a matched population-based analysis. Am J Sports Med 2017;45:1012–7. 10.1177/0363546516680604 [DOI] [PubMed] [Google Scholar]
- 97. Snoeker B, Turkiewicz A, Magnusson K, et al. Risk of knee osteoarthritis after different types of knee injuries in young adults: a population-based cohort study. Br J Sports Med 2020;54:725–30. 10.1136/bjsports-2019-100959 [DOI] [PubMed] [Google Scholar]
- 98. von Porat A, Roos EM, Roos H. High prevalence of osteoarthritis 14 years after an anterior cruciate ligament tear in male soccer players: a study of radiographic and patient relevant outcomes. Ann Rheum Dis 2004;63:263–63. 10.1136/ard.2003.008136 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99. Poulsen E, Goncalves GH, Bricca A, et al. Knee osteoarthritis risk is increased 4-6 fold after knee injury - a systematic review and meta-analysis. Br J Sports Med 2019;53:1454–63. 10.1136/bjsports-2018-100022 [DOI] [PubMed] [Google Scholar]
- 100. Westreich D, Greenland S. The table 2 fallacy: presenting and interpreting confounder and modifier coefficients. Am J Epidemiol 2013;177:292–8. 10.1093/aje/kws412 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101. Mahmoudian A, Lohmander LS, Mobasheri A, et al. Early-stage symptomatic osteoarthritis of the knee - time for action. Nat Rev Rheumatol 2021;17:621–32. 10.1038/s41584-021-00673-4 [DOI] [PubMed] [Google Scholar]
- 102. Hawker GA, Lohmander LS. What an earlier recognition of osteoarthritis can do for oa prevention. Osteoarthritis and Cartilage 2021;29:1632–4. 10.1016/j.joca.2021.08.007 [DOI] [PubMed] [Google Scholar]
- 103. Moher D, Hopewell S, Schulz KF, et al. Consort 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c869. 10.1136/bmj.c869 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104. von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg 2014;12:1495–9. 10.1016/j.ijsu.2014.07.013 [DOI] [PubMed] [Google Scholar]
- 105. Whittaker JL, Roos EM. A pragmatic approach to prevent post-traumatic osteoarthritis after sport or exercise-related joint injury. Best Pract Res Clin Rheumatol 2019;33:158–71. 10.1016/j.berh.2019.02.008 [DOI] [PubMed] [Google Scholar]
- 106. Silverwood V, Blagojevic-Bucknall M, Jinks C, et al. Current evidence on risk factors for knee osteoarthritis in older adults: a systematic review and meta-analysis. Osteoarthritis Cartilage 2015;23:507–15. 10.1016/j.joca.2014.11.019 [DOI] [PubMed] [Google Scholar]
- 107. Lee R, Kean WF. Obesity and knee osteoarthritis. Inflammopharmacology 2012;20:53–8. 10.1007/s10787-011-0118-0 [DOI] [PubMed] [Google Scholar]
- 108. Blagojevic M, Jinks C, Jeffery A, et al. Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis. Osteoarthritis Cartilage 2010;18:24–33. 10.1016/j.joca.2009.08.010 [DOI] [PubMed] [Google Scholar]
- 109. Øiestad BE, Juhl CB, Eitzen I, et al. Knee extensor muscle weakness is a risk factor for development of knee osteoarthritis. A systematic review and meta-analysis. Osteoarthritis Cartilage 2015;23:171–7. 10.1016/j.joca.2014.10.008 [DOI] [PubMed] [Google Scholar]
- 110. Siegel MG. Editorial Commentary: "Defer No Time, Delays Have Dangerous Ends" (Henry VI, Shakespeare): Delayed Anterior Cruciate Ligament Reconstruction Has Consequences. Arthroscopy 2018;34:1918–20. 10.1016/j.arthro.2018.02.017 [DOI] [PubMed] [Google Scholar]
- 111. Van Ginckel A, Verdonk P, Victor J, et al. Cartilage status in relation to return to sports after anterior cruciate ligament reconstruction. Am J Sports Med 2013;41:550–9. 10.1177/0363546512473568 [DOI] [PubMed] [Google Scholar]
- 112. Øiestad BE, Holm I, Risberg MA. Return to pivoting sport after ACL reconstruction: association with osteoarthritis and knee function at the 15-year follow-up. Br J Sports Med 2018;52:1199–204. 10.1136/bjsports-2017-097718 [DOI] [PubMed] [Google Scholar]
- 113. Risberg MA, Grindem H, Øiestad BE. We need to implement current evidence in early rehabilitation programs to improve long-term outcome after anterior cruciate ligament injury. J Orthop Sports Phys Ther 2016;46:710–3. 10.2519/jospt.2016.0608 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
bjsports-2022-105496supp001.pdf (1.4MB, pdf)




